Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NOVAVAX INC Director's Dealing 2014

Jun 17, 2014

31982_dirs_2014-06-17_c18e0911-4c0d-4735-a556-882ef91a93c1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2014-06-13

Reporting Person: Trizzino John (SVP, Commercial Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-06-13 Common Stock P 11000 $4.474 Acquired 11000 Direct
2014-06-16 Common Stock P 4800 $4.589 Acquired 15800 Direct
2014-06-16 Common Stock P 700 $4.59 Acquired 16500 Direct